ReviewActa neurologica Belgica2026
Anti-Yo related pure sensory ganglionopathy: a rare paraneoplastic entity.
Review in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSensory ganglionopathy (SG) results from involvement of the dorsal root ganglia. Clinically, it presents with asymmetric, usually non-length-dependent, sensory symptoms, sensory ataxia and reduced or absent tendon reflexes. Electrophysiologically, there is an absence or asymmetry of sensory nerve action potentials (SNAPs). Etiologies include genetic, autoimmune, and paraneoplastic causes. METHODS AND MATERIALS: Case report and review of the literature.
resultsWe report a case of pure sensory ganglionopathy (SG) without cerebellar involvement associated with anti-Yo antibodies. A 78-year-old woman presented with a two-year history of progressive limb paresthesias. Electrophysiological studies demonstrated a non-length-dependent asymmetric sensory neuropathy with normal motor conduction studies, pointing toward SG, and serological testing was positive for anti-Yo antibodies. Initial FDG-PET imaging was unremarkable; however, repeat imaging identified two hypermetabolic foci in the right breast. The patient subsequently underwent a partial mastectomy, and histopathological analysis confirmed infiltrating papillary, hormone receptor-positive carcinoma. Following oncological treatment, the patient remained clinically and neurophysiologically stable, with mild subjective improvement in numbness. Pure SG associated with anti-Yo antibodies is exceedingly rare, with only two previously reported cases-one linked to breast cancer and another to ovarian cancer.
conclusionsDiagnosing SG is challenging, and the presence of anti-Yo antibodies together with electrophysiological findings should raise suspicion, even in the absence of cerebellar involvement. Thorough evaluation and close oncological follow-up are essential.
Indexed as
Identifiers
42287493What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.